PathPresenter Welcomes Patrick Myles as CEO

April 26, 2022

PathPresenter, the most widely used digital pathology workflow platform with 40,000 users in 172 countries, today announced the appointment of Patrick Myles, as CEO and Chairman of the Board. An experienced digital healthcare executive, Patrick will succeed Naghi Prasad and assume responsibilities on April 25, 2022. Naghi Prasad will continue to be associated with PathPresenter as a Board member and an advisor.

“Patrick is a natural fit to lead PathPresenter into its next stage of growth,” said co-founder, Dr. Rajendra Singh. “He brings to the company extensive industry-specific experience, as well as an excellent reputation, broad network, and leadership abilities that will be beneficial as we embark on the next stage of our explosive growth”.

“I am honored and humbled to join the PathPresenter team,” said Patrick Myles. “It is truly impressive and unique how the team has built such a large and engaged world-wide community of PathPresenter users. I am particularly excited to realize the full commercial potential of the newly launched ClinPX Digital Pathology Practice platform, which I believe is at the leading edge of digital transformation of clinical pathology practices across the world”.

Patrick was most recently the CEO of Huron Digital Pathology, a whole slide scanner company and pioneer in AI-enabled image-based search. He served for four years as a board member of the Digital Pathology Association. Prior to Huron, Patrick was Vice President, Business Development and Communications at Teledyne DALSA, a world-leading digital imaging company. He has an MBA from Wilfrid Laurier University and a Bachelor of Arts degree from the University of Waterloo.

PathPresenter Introduces Clinical Consultation Platform for Remote 2nd Opinion

APR 13, 2022

Pilot installation at The Ohio State University integrates PathPresenter’s clinical consultation platform into Epic’s Beaker Laboratory Information System (LIS), allowing The Ohio State University (OSU) pathologists to receive, view, and sign out cases – uploaded from around the world – directly in Beaker.

PathPresenter, the premier digital pathology platform for education and conferences with more than 40,000 users and 20+ institutional licenses, now presents to clinical users a best-in-class clinical enterprise platform.

PathPresenter has introduced is a custom, institution-branded, clinical enterprise platform that enables pathology consultations to be directly viewed and reported in an institution’s LIS through the company’s proprietary backend HL7 messaging engine.

It has inbuilt quality control (QC) ensuring whole slide images are of diagnostic quality and has the ability to integrate validated AI models into the scanner-agonistic viewer.

The clinical consultation platform allows a seamless and intuitive consultation workflow, as well as in-house consensus, tumor board meetings or live discussions with referring pathologists as well as bidirectional communication channels for ordering stains and recuts. It also enables routing interesting cases into folders for de-identification and use in tumor boards, conferences, research, or education. This functionality brings the control and organization of the clinical workflow back to the end user.

Our first pilot installation with The Ohio State University Wexner Medical Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) integrates the platform into Epic’s Beaker LIS, allowing pathologists at The Ohio State University to receive, view, and sign out cases uploaded from around the world directly in Beaker.

“Our goal is to use PathPresenter’s clinical consultation platform to augment OSU’s pathology clinical consultation capabilities globally. The platform has the ability to integrate with multiple AI vendors with the overall goal of improving patient care and making pathology diagnosis more robust, timely and accurate,” said Dr. Anil Parwani, vice chair of anatomic pathology at The Ohio State University College of Medicine.

Rajendra Singh, co-founder of PathPresenter, added “we have created a solution to allow for the integration of digital pathology into existing workflows used by pathologists without disruption.”

This platform is installed as a pilot project at The Ohio State University for potential expansion of its digital pathology consultation service. Dr. Parwani has no personal conflicts of interest to disclose.

4D Path, PathPresenter Announce Partnership to Advance AI-enabled Digital Pathology for End-to-End Breast Tumor Profiling